DoubleVerify to Announce Second Quarter 2024 Financial Results on July 30, 2024
DoubleVerify to Announce Second Quarter 2024 Financial Results on July 30, 2024
DoubleVerify (“DV”) (NYSE: DV), a leading software platform for digital media measurement, data, and analytics, today announced that it will report second quarter 2024 financial results after the market close on Tuesday, July 30, 2024. Management will host a conference call and webcast to discuss DV's financial results, recent developments and business outlook at 4:30 p.m. ET following the release of the financial results.
What: |
DoubleVerify Second Quarter 2024 Financial Results Conference Call |
|
When: |
Tuesday, July 30, 2024 |
|
Time: |
4:30 p.m. ET |
|
Live Call: |
US/Canada Toll-Free: (877) 841-2987 |
|
International: +1 (215) 268-9878 |
||
Webcast: |
About DoubleVerify
DoubleVerify is the industry’s leading media effectiveness platform that leverages AI to drive superior outcomes for global brands. By creating more effective, transparent ad transactions, we make the digital advertising ecosystem stronger, safer and more secure, thereby preserving the fair value exchange between buyers and sellers of digital media. Learn more at www.doubleverify.com.
Investor Relations
Tejal Engman
DoubleVerify
IR@doubleverify.com
Media Contact
Chris Harihar
Crenshaw Communications
646-535-9475
chris@crenshawcomm.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240709750169/en/
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks